206 related articles for article (PubMed ID: 21907959)
1. Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia.
Pachman DR; Barton DL; Clayton AC; McGovern RM; Jefferies JA; Novotny PJ; Sloan JA; Loprinzi CL; Gostout BS
Am J Obstet Gynecol; 2012 Jan; 206(1):42.e1-7. PubMed ID: 21907959
[TBL] [Abstract][Full Text] [Related]
2. Treatment of cervical intraepithelial neoplasia with topical imiquimod: a randomized controlled trial.
Grimm C; Polterauer S; Natter C; Rahhal J; Hefler L; Tempfer CB; Heinze G; Stary G; Reinthaller A; Speiser P
Obstet Gynecol; 2012 Jul; 120(1):152-9. PubMed ID: 22914404
[TBL] [Abstract][Full Text] [Related]
3. Imiquimod in cervical, vaginal and vulvar intraepithelial neoplasia: a review.
de Witte CJ; van de Sande AJ; van Beekhuizen HJ; Koeneman MM; Kruse AJ; Gerestein CG
Gynecol Oncol; 2015 Nov; 139(2):377-84. PubMed ID: 26335596
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of imiquimod 5% cream for persistent human papillomavirus in genital intraepithelial neoplasm.
Chen FP
Taiwan J Obstet Gynecol; 2013 Dec; 52(4):475-8. PubMed ID: 24411029
[TBL] [Abstract][Full Text] [Related]
5. TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC trial): study protocol for a randomized controlled trial.
Koeneman MM; Kruse AJ; Kooreman LFS; Zur Hausen A; Hopman AHN; Sep SJS; Van Gorp T; Slangen BFM; van Beekhuizen HJ; van de Sande M; Gerestein CG; Nijman HW; Kruitwagen RFPM
BMC Cancer; 2016 Feb; 16():132. PubMed ID: 26897518
[TBL] [Abstract][Full Text] [Related]
6. Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147).
Sheth SS; Oh JE; Bellone S; Siegel ER; Greenman M; Mutlu L; McNamara B; Pathy S; Clark M; Azodi M; Altwerger G; Andikyan V; Huang G; Ratner E; Kim DJ; Iwasaki A; Levi AW; Buza N; Hui P; Flaherty S; Schwartz PE; Santin AD
Clin Cancer Res; 2024 May; 30(9):1768-1777. PubMed ID: 38592381
[TBL] [Abstract][Full Text] [Related]
7. [Imiquimod and immune response modifiers in gynaecology].
Baulon E; Vautravers A; Rodriguez B; Nisand I; Baldauf JJ
Gynecol Obstet Fertil; 2007 Feb; 35(2):149-57. PubMed ID: 17300975
[TBL] [Abstract][Full Text] [Related]
8. Intrabody strategies for the treatment of human papillomavirus-associated disease.
Doorbar J; Griffin H
Expert Opin Biol Ther; 2007 May; 7(5):677-89. PubMed ID: 17477805
[TBL] [Abstract][Full Text] [Related]
9. Topical Imiquimod for the Treatment of High-Grade Squamous Intraepithelial Lesions of the Cervix: A Randomized Controlled Trial.
Fonseca BO; Possati-Resende JC; Salcedo MP; Schmeler KM; Accorsi GS; Fregnani JHTG; Antoniazzi M; Pantano NP; Santana IVV; Matsushita GM; Dos Reis R
Obstet Gynecol; 2021 Jun; 137(6):1043-1053. PubMed ID: 33957649
[TBL] [Abstract][Full Text] [Related]
10. TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia (TOPIC-2 trial): a study protocol for a randomized controlled trial.
van de Sande AJM; Koeneman MM; Gerestein CG; Kruse AJ; van Kemenade FJ; van Beekhuizen HJ
BMC Cancer; 2018 Jun; 18(1):655. PubMed ID: 29902979
[TBL] [Abstract][Full Text] [Related]
11. Imiquimod for genital warts.
Med Lett Drugs Ther; 1997 Dec; 39(1016):118-9. PubMed ID: 9422045
[No Abstract] [Full Text] [Related]
12. Subclinical cervicovaginal human papillomavirus infections associated with cervical condylomata and dysplasia. Treatment outcomes.
Husseinzadeh N; Guoth JG; Jayawardena DS
J Reprod Med; 1994 Oct; 39(10):777-80. PubMed ID: 7837123
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of 5% imiquimod for the treatment of Vaginal intraepithelial neoplasia-A systematic review of the literature and a meta-analysis.
Tranoulis A; Laios A; Mitsopoulos V; Lutchman-Singh K; Thomakos N
Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():129-136. PubMed ID: 28985547
[TBL] [Abstract][Full Text] [Related]
14. [Topical imiquimod cream in the treatment of external anogenital warts: personal experience].
Senatori R; Dionisi B; Lippa P; Inghirami P
Minerva Ginecol; 2003 Dec; 55(6):541-6. PubMed ID: 14676745
[TBL] [Abstract][Full Text] [Related]
15. Preliminary stop of the TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC) trial.
Koeneman MM; Kruse AJ; Kooreman LF; Zur Hausen A; Hopman AH; Sep SJ; Van Gorp T; Slangen BF; van Beekhuizen HJ; van de Sande AJ; Gerestein CG; Nijman HW; Kruitwagen RF
BMC Cancer; 2017 Feb; 17(1):110. PubMed ID: 28173776
[TBL] [Abstract][Full Text] [Related]
16. [Item 149--Epithelial and melanotic skin tumors: human papillomavirus (HPV) tumors].
CEDEF
Ann Dermatol Venereol; 2012 Oct; 139(11 Suppl):A144-9. PubMed ID: 23176836
[No Abstract] [Full Text] [Related]
17. Clinical and molecular responses in high-grade intraepithelial neoplasia treated with topical imiquimod 5%.
Diaz-Arrastia C; Arany I; Robazetti SC; Dinh TV; Gatalica Z; Tyring SK; Hannigan E
Clin Cancer Res; 2001 Oct; 7(10):3031-3. PubMed ID: 11595691
[TBL] [Abstract][Full Text] [Related]
18. Management of female genital warts with an analog of imiquimod 2% in cream: a randomized, double-blind, placebo-controlled study.
Syed TA; Ahmadpour OA; Ahmad SA; Ahmad SH
J Dermatol; 1998 Jul; 25(7):429-33. PubMed ID: 9714974
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV-positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia.
Sanclemente G; Herrera S; Tyring SK; Rady PL; Zuleta JJ; Correa LA; He Q; Wolff JC
J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1054-60. PubMed ID: 17714124
[TBL] [Abstract][Full Text] [Related]
20. Topical imiquimod treatment for human papillomavirus infection in patients with and without cervical/vaginal intraepithelial neoplasia.
Lin CT; Qiu JT; Wang CJ; Chang SD; Tang YH; Wu PJ; Jung SM; Huang CC; Chou HH; Jao MS; Lai CH
Taiwan J Obstet Gynecol; 2012 Dec; 51(4):533-8. PubMed ID: 23276555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]